85 Multidrug-Resistant Gram Negative Rods (MDR-GNR)

Saturday, March 20, 2010: 4:00 PM-6:00 PM
Regency VI-VII (Hyatt Regency Atlanta)
CME Credits: 2
Type: Oral
Summary: MDR-GNR have become a major challenge in healthcare facilities around the world. Though regional differences exist among the types of pathogens and resistance patterns that are of most concern, there is a common belief that these pathogens pose a growing threat to patient safety. This symposium will review the changing, worldwide epidemiology of MDR-GNR over the past decade and set the current stage of this problem. Other speakers will then discuss optimal infection control approaches to MDR-GNR and describe the gaps in our current knowledge of MDR control and issues surrounding new drug development for MDR-GNR.
Learning Objectives:
David Calfee, MD and Anna-Pelagia Magiorakos, MD
4:00 PM
Changing Epidemiology of MDR-GNR - The Americas
Alexander Kallen, MD, MPH, Centers for Disease Control and Prevention
4:20 PM
Changing Epidemiology of MDR-GNR: Europe and Asia
David L. Paterson, MD, University of Queensland Centre for Clinical Research
4:40 PM
Infection Control Approaches to MDR-GNR: Where Are We Now? Where Are We Going?
Yehuda Carmelli, MD, MPH, Tel Aviv Sourasky Medical Center
5:00 PM
Drug Development for MDR-GNR: Current and Future Landscapes
George Talbot, MD, Talbot Advisors LLC